Woodline Partners LP
Institutional investor · Portfolio as of Q3 2024
Top Holdings586 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
META PLATFORMS INC-CLASS A | 422,215 | $241.7M | 2.0% | $363.70 | +55.38% | 9 qtrssince 2022-Q3 | Increased 78 |
GILEAD SCIENCES INC | 1.9M | $161.6M | 1.4% | $74.66 | +8.04% | 15 qtrssince 2021-Q1 | Increased 76 |
ABBVIE INC | 808,736 | $159.7M | 1.3% | $140.87 | +31.27% | 9 qtrssince 2022-Q3 | Increased 52 |
REVOLUTION MEDICINES INC | 3.4M | $155.7M | 1.3% | $25.27 | +74.81% | 17 qtrssince 2020-Q3 | Increased 50 |
VAXCYTE INC | 1.1M | $126.1M | 1.1% | $74.74 | +51.39% | 10 qtrssince 2022-Q2 | Increased 67 |
ASML HOLDING NV-NY REG SHS | 149,876 | $124.9M | 1.1% | $819.51 | 0.00% | 1 qtr | New 69 |
Nuvalent, Inc. Class A | 1.2M | $122.1M | 1.0% | $80.49 | +23.12% | 6 qtrssince 2023-Q2 | Increased 61 |
PERMIAN RESOURCES CORP | 8.7M | $118.2M | 1.0% | $11.75 | +8.98% | 6 qtrssince 2023-Q2 | Increased 52 |
OVINTIV INC | 3M | $114.3M | 1.0% | $42.76 | -13.53% | 5 qtrssince 2023-Q3 | Decreased 0 |
KEYSIGHT TECHNOLOGIES IN | 712,588 | $113.3M | 1.0% | $150.03 | +5.78% | 7 qtrssince 2023-Q1 | Increased 48 |
DANAHER CORP | 393,300 | $109.3M | 0.9% | $251.01 | +8.92% | 4 qtrssince 2023-Q4 | Increased 60 |
AON PLC | 309,754 | $107.2M | 0.9% | $337.40 | +1.47% | 3 qtrssince 2024-Q1 | Increased 68 |
STMICROELECTRONICS NV-NY SHS | 3.5M | $105.3M | 0.9% | $30.91 | -3.42% | 2 qtrssince 2024-Q2 | Increased 68 |
REGENERON PHARMACEUTICALS | 99,417 | $104.5M | 0.9% | $796.74 | +30.15% | 16 qtrssince 2020-Q4 | Decreased 0 |
EQT CORP | 2.8M | $103.3M | 0.9% | $37.90 | -5.71% | 6 qtrssince 2023-Q2 | Increased 53 |
L3HARRIS TECHNOLOGIES INC | 432,141 | $102.8M | 0.9% | $202.98 | +13.06% | 12 qtrssince 2021-Q4 | Increased 54 |
GULFPORT ENERGY CORP | 675,342 | $102.2M | 0.9% | $125.53 | +21.04% | 6 qtrssince 2023-Q2 | Increased 62 |
ELI LILLY & CO | 114,427 | $101.4M | 0.9% | $422.06 | +107.01% | 20 qtrssince 2019-Q4 | Decreased 0 |
ROIVANT SCIENCES LTD | 8.7M | $100.2M | 0.8% | $9.59 | +19.71% | 9 qtrssince 2022-Q3 | Increased 46 |
AMGEN INC | 307,950 | $99.2M | 0.8% | $266.34 | +14.57% | 8 qtrssince 2022-Q4 | Increased 45 |
Woodline Partners LP manages $11.9B across 586 positions as of Q3 2024. Top holdings: META (2.0%), GILD (1.4%), ABBV (1.3%). Fund DNA: Diversified Scout. HoldingsIntel Rating: 2/5.0.
Active quarter - 202 new positions, 160 exits, 219 increased. Top move: META (INCREASED, conviction 78). Portfolio: $11.9B across 586 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer